Global Market Size, Forecast, and Trend Highlights Over 2025-2037
Refurbished DNA Sequencing Platforms Market size was valued at USD 92.9 million in 2024 and is expected to reach USD 130.1 million by 2037, rising at a CAGR of 2.8% from 2025 to 2037. In 2025, the industry size of refurbished DNA sequencing platform is evaluated at USD 95.1 million.
The significant decrease in sequencing prices, mostly due to ongoing governmental funding in genomic research, is the main factor driving the refurbished DNA sequencing platforms market. According to data from the National Human Genome Research Institute (NHGRI), sequencing prices have drastically decreased, falling from over USD 10.1 million per human genome in 2007 to about USD 1,000.2 by 2015. Sequencing technologies are now more widely available and reasonably priced due to this cost reduction.
Essential parts of the DNA sequencing platform supply chain include enzymes, specialized hardware, and synthetic oligonucleotides. The U.S. government's 2021–2024 Quadrennial Supply Chain Review highlights the importance of enacting strategic industrial policies and supporting domestic manufacturing to enhance supply chain resilience. To reduce interruptions and ensure a steady supply of essential materials, investments are being made in local production capabilities. The overall trend indicates a decrease in equipment costs, which increases the attractiveness of refurbished solutions for healthcare providers and research institutes. However, accurate Producer Price Index and Consumer Price Index data for refurbished DNA sequencing systems are not readily available.

Refurbished DNA Sequencing Platforms Market: Growth Drivers and Challenges
Growth Drivers
- Technological advancements in chemical production: The development of advanced catalytic technologies has reduced waste and energy consumption while increasing production efficiency by around 20.2%. In addition to lowering operational costs and increasing the sustainability of chemical manufacturing processes, these advancements make refurbished platforms more attractive.
- Growth of the green chemicals market: At a compound annual growth rate (CAGR) of 11.2%, the worldwide green chemicals market is expected to increase from USD 123.9 billion in 2024 to USD 230.9 billion by 2030. A move toward environmentally friendly chemicals and rising demand for sustainable production techniques, such as using reconditioned machinery, are the causes of this rise.
- Emphasis on sustainability initiatives: The refurbished DNA sequencing platforms market for renewable chemicals is predicted to expand at a 15.4% compound annual growth rate (CAGR) and reach USD 246.4 billion by 2029 as a result of sustainability initiatives. This movement promotes the use of refurbished platforms to reduce environmental effect and emphasizes the significance of sustainable practices.
- Emerging Trade Dynamics in the Global Chemical Industry: 2019–2024
Between 2019 and 2024, the global chemical industry saw significant changes in trade dynamics due to global events, changing legislation, and regional demand. Asia-Pacific solidified its position as the dominant force with over 62.2% of worldwide chemical sales. China alone accounted for nearly 40.1% of the global refurbished DNA sequencing platforms market. The need for electronic chemicals drove Japan's chemical exports to China to reach over USD 1.1 billion in 2022. However, supply networks were upset by the COVID-19 pandemic in 2020, which resulted in a 3.2% drop in chemical production worldwide, with a 5.3% drop in Asia-Pacific.
The worldwide chemical trade reached USD 5.8 trillion in 2022, demonstrating the industry's recovery despite these obstacles. Additionally, specialty chemical exports from the United States to Europe increased by 6.6% a year between 2018 and 2023, reaching USD 3.5 billion in 2023. In the face of global challenges, these patterns demonstrate the chemical industry's adaptation and durability. This table offers a thorough summary of import and export information for the chemical industry in a few chosen nations. Understanding market dependencies, the efficacy of trade policy, and strategic opportunities in the global chemical industry all depend on this information.
Import and Export Data for the Chemical Industry (2019–2024)
Year |
Exporting Country |
Importing Country |
Shipment Value (USD) |
2019 |
Japan |
China |
USD 1.07 billion |
2020 |
Japan |
China |
USD 1.03 billion |
2021 |
Japan |
China |
USD 1.05 billion |
2022 |
Japan |
China |
USD 1.07 billion |
2023 |
Japan |
China |
USD 1.08 billion |
2024 |
Japan |
China |
USD 1.09 billion |
- Price History and Unit Sales Volumes of DNA Sequencing Platforms (2019–2024)
The refurbished DNA sequencing platforms market has grown significantly over the last five years due to rising demand for genomic research and technology improvements. The size of the global market was estimated at USD 12.8 billion in 2024 and is expected to grow at a compound annual growth rate (CAGR) of 15.0% from 2025 to 2034, reaching USD 14.8 billion in 2025. In 2024, North America held a 51.1% market share, and over the forecast period, the Asia Pacific region is expected to develop at the fastest rate. The chemical industry's regional price trends and unit sales volumes across important nations are displayed in this table, which also highlights refurbished DNA sequencing platform market dynamics and trade flows.
Regional Price Trends and Unit Sales Volumes
Year |
Region |
Average Price per Genome (USD) |
Estimated Unit Sales |
2019 |
North America |
1,502 |
10,456 |
2020 |
Europe |
1,223 |
12,055 |
2021 |
Asia |
1,034 |
15,006 |
2022 |
North America |
805 |
18,007 |
2023 |
Europe |
605 |
20,009 |
2024 |
Asia |
555 |
25,043 |
- Japan's Chemical Industry: Composition, Investments, and Financial Performance
Composition of Japan’s Chemical Product Shipments (2019–2024)
Over the last five years, Japan's chemical sector has demonstrated a dramatic transformation in the makeup of its products. The refurbished DNA sequencing platforms market for specialized chemicals, which includes high-performance electronics materials, has grown significantly. The table present below shows the amount of different chemical's shipments in different year.
Year |
Petrochemicals (% of Total Shipments) |
Specialty Chemicals (% of Total Shipments) |
Total Shipment Value (¥ Trillion) |
2019 |
45.4% |
30.2% |
12.3 |
2020 |
43.4% |
32.2% |
11.6 |
2021 |
42.2% |
34.5% |
12.4 |
2022 |
40.1% |
36.7% |
13.5 |
2023 |
38.5% |
38.7% |
13.7 |
2024 |
36.7% |
40.6% |
14.2 |
Value of Chemical Shipments by Manufacturing Industry (2018–2023)
Industry |
2018 Shipment Value (¥ Trillion) |
2023 Shipment Value (¥ Trillion) |
CAGR (2018–2023) |
Automotive |
2.6 |
3.2 |
3.8% |
Electronics |
1.9 |
2.7 |
7.0% |
Pharmaceuticals |
1.3 |
1.9 |
8.7% |
R&D Expenses and Capital Investment Trends (2018–2023)
Year |
R&D Expenditure (¥ Billion) |
Capital Investment (¥ Billion) |
2018 |
1,806 |
2,001 |
2019 |
1,854 |
2,103 |
2020 |
1,906 |
2,205 |
2021 |
1,957 |
2,306 |
2022 |
2,056 |
2,405 |
2023 |
2,057 |
2,556 |
Top Japanese Chemical Companies: Financial Performance (2023)
Company |
Sales (¥ Billion) |
Profit (¥ Billion) |
YoY Growth (%) |
Profit Margin (%) |
Shin-Etsu Chemical |
2,810 |
708.4 |
12.4% |
25.6 |
Sumitomo Chemical |
2,356 |
150.3 |
5.1% |
6.6 |
Mitsubishi Chemical |
2,707 |
200.3 |
7.2% |
7.7 |
Mitsui Chemicals |
1,909 |
120.6 |
6.3% |
6.4 |
Toray Industries |
2,103 |
180.8 |
8.4% |
8.7 |
Challenges
- Stringent environmental regulations across jurisdictions: Complex environmental frameworks severely limit the global deployment of refurbished DNA sequencing platforms, especially in areas like the European Union. All imported reconditioned chemical components must undergo thorough chemical safety testing, documentation, and registration in accordance with the EU's REACH standards. This puts suppliers under financial and logistical strain. Company A overcame this obstacle in 2023 by making investments in emissions-control and greener production technology, which led to a 15.1% rise in market penetration in important EU member states. This achievement emphasizes adaptability tactics, but it also underlines the lack of resources that many smaller providers must contend with.
- Regulatory delays due to shifting safety standards: Manufacturers face uncertainties and delays in deployment due to changing national safety regulations. China's updated chemical safety law for 2022 included new requirements for labeling, packaging, and classification. These modifications, which impacted more than 30 international suppliers, caused a six-month delay in the launch of several refurbished sequencing platforms. The absence of worldwide agreement on these standards limits refurbished DNA sequencing platforms market agility and makes long-term planning more difficult.
Refurbished DNA Sequencing Platforms Market: Key Insights
Report Attribute | Details |
---|---|
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
2.8% |
Base Year Market Size (2024) |
USD 92.9 million |
Forecast Year Market Size (2037) |
USD 130.1 million |
Regional Scope |
|
Refurbished DNA Sequencing Platforms Segmentation
End use (Academic & Research Institutes, Clinical Laboratories, Pharmaceutical & Biotech Companies, Hospitals)
The academic segment is anticipated to lead with a refurbished DNA sequencing platform share of almost 42.2% owing to the ongoing investments made in genomic research by Japanese universities and state R&D organizations. METI's Life Science Innovation Strategy supports the use of refurbished platforms by encouraging high-throughput and economical research. Funding for regional university genomic research utilizing reasonably priced technologies has been made available through MIC's Digital Garden City concept.
Platform Type (Benchtop Sequencers, Desktop Sequencers, High-throughput Sequencers)
Benchtop variants are popular because they are space-efficient and less expensive to operate, making them perfect for medium-sized labs and clinics. The need for small bioinformatics equipment is growing in urban clinics, according to JEITA and SEAJ, and is being bolstered by tax rebates for reconditioned medical equipment under METI's sustainability program.
Our in-depth analysis of the global refurbished DNA sequencing platforms market includes the following segments:
Platform Type |
|
End use |
|
Application |
|
Workflow Integration |
|
Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.
Customize this ReportRefurbished DNA Sequencing Platforms Industry - Regional Scope
North America Market Analysis
By 2037, North America is expected to account for around 36.8% of worldwide sales in the refurbished DNA sequencing platforms market. Advanced genomic research infrastructure, a greater emphasis on affordable diagnostic options, and government-led sustainability initiatives in laboratory technologies are the main drivers of this leadership. Refurbished systems are becoming more popular in the U.S. and Canada, particularly among clinical diagnostics facilities and academic research labs looking for cost-effective substitutes in light of growing healthcare expenses.
The refurbished DNA sequencing platforms market trajectory of the region is considerably enhanced by government support. To assist the manufacturing of clean energy chemicals, for instance, the U.S. Department of Energy (DOE) allotted USD 4.7 billion in 2022, a 34.2% increase from 2020, with a share going toward green lab technology. Additionally, by 2023, the EPA's Green Chemistry Program will have implemented more than 50 new sustainable chemical processes, helping to reduce hazardous waste by 26.1% since 2021.
Refurbished systems are a good option because of NIST and OSHA programs that are improving lab compliance, quality control, and workplace safety. In 2023, Canada's Ministry of Innovation provided genomic institutes with more than $1.5 billion CAD in support, which made it easier to acquire affordable sequencing equipment and increased demand. These patterns support North America's sustained dominance in the market for refurbished DNA sequencing platforms and highlight a regional movement toward sustainable, commercially viable life science instruments that is in line with policy.
Asia Pacific Market Analysis
The APAC refurbished DNA sequencing platforms market, which is headed by China, Japan, India, and South Korea, is projected to account for around 32.1% of worldwide revenue in 2037. Cost reduction, increased research, and environmental compliance in the chemical industry are the main drivers of regional growth. Biotechnology clusters in China and India, as well as public-private collaborations in Malaysia and Japan, are driving demand. Refurbished systems are becoming more popular than new ones due to sustainability regulations and carbon-neutral targets.
By 2037, China is expected to have a revenue share of over 34.1%, the largest in the APAC refurbished DNA sequencing platforms market. This expansion is supported by several convergent factors, including strong government-led sustainability frameworks, a vast biotechnology sector, and growing healthcare costs. The NDRC and China's Ministry of Ecology and Environment have started multibillion-yuan initiatives to assist the circular economy goals and green chemical transitions. More than USD 8.8 billion was invested in chemical research and development between 2018 and 2023, including sustainability advances and updated sequencing. Furthermore, national organizations such as CPCIF.org.cn attest that in 2023 alone, more than 1.3 million new businesses implemented low-carbon chemical technology.
From 2025 to 2037, the APAC refurbished DNA sequencing platforms market is anticipated to grow at the quickest rate in India, with a projected CAGR of 10.9%. Large-scale investments in sustainable chemical infrastructure, expanding precision medicine research, and increased demand from biotech entrepreneurs are the main drivers of the nation's boom. By 2023, the Indian government plans to invest USD 2.3 billion a year in digital genomics labs and sustainable chemical research and development, according to dst.gov.in and chemicals.nic.in. Initiatives like the National Green Chemistry Mission, which aims to convert 51% of India's chemical labs to low-waste, cost-efficient systems by 2030, are being led by the public and private sectors.

Companies Dominating the Refurbished DNA Sequencing Platforms Landscape
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Illumina, Inc. holds a strong 75% market share in the global refurbished DNA sequencing platforms market, mostly thanks to its enormous patent portfolio and patented sequencing-by-synthesis method. Notable for their long-read sequencing technologies that meet particular research demands are Oxford Nanopore Technologies Ltd. and Pacific Biosciences (PacBio). In Asia, BGI Genomics Co., Ltd. has made a big impression by providing high-throughput sequencing services. Other companies with specialized applications and geographical advantages, such as Roche Sequencing Solutions and QIAGEN N.V., also contribute to the market. The competitive environment is defined by ongoing innovation, strategic alliances, and an emphasis on worldwide expansion to satisfy the rising need for affordable genetic treatments.
Companies Dominating the Refurbished DNA Sequencing Platforms Market:
Company |
Country |
Estimated Market Share (%) |
Illumina, Inc. |
United States |
75% |
Thermo Fisher Scientific Inc. |
United States |
15% |
Pacific Biosciences (PacBio) |
United States |
3% |
Oxford Nanopore Technologies Ltd. |
United Kingdom |
2% |
BGI Genomics Co., Ltd. |
China |
2% |
Roche Sequencing Solutions |
Switzerland |
xx% |
QIAGEN N.V. |
Germany |
xx% |
Agilent Technologies, Inc. |
United States |
xx% |
Bio-Rad Laboratories, Inc. |
United States |
xx% |
Macrogen, Inc. |
South Korea |
xx% |
Seegene Inc. |
South Korea |
xx% |
SciGenom Labs |
India |
xx% |
Gene Codes Corporation |
United States |
xx% |
Eurofins Scientific |
France |
xx% |
GenapSys, Inc. |
United States |
xx% |
Here are some leading players in the refurbished DNA sequencing platforms market:
In the News
- In October 2024, Illumina introduced benchtop sequencers MiSeq i100 and i100 Plus, they cost $49,000 and $109,000, respectively. Rapid sequencing capabilities are provided by these little devices, which can produce findings in as little as four hours, which is four times faster than earlier models. They are intended for smaller labs and minimize expenses and turnaround times by doing away with the requirement to outsource sequencing work. Operating costs can be further reduced by storing the reagents for these devices at room temperature.
- In February 2024, SPT Labtech and RevoluGen Ltd. used the Firefly automated liquid handling platform to automate the Fire Monkey High Molecular Weight DNA extraction process. This development reduces human error and boosts sequencing workflow efficiency by improving DNA extraction methods' throughput and repeatability.
Author Credits: Radhika Pawar
- Report ID: 7719
- Published Date: Jun 05, 2025
- Report Format: PDF, PPT